This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
05 May 2014 | Asia Pacific | Market Research
Russia Hematology Diagnostics Market Data
Russian Governments Support for Development of In Vitro Diagnostic Industry Propels Adoption of High End Analyzers
This study provides market data for the Russian hematology diagnostics market. Segments in the market include instruments and reagents. Instruments are further segmented by 5PD and 3PD analyzers. Market revenues, installed base units, and market share are included in this deliverable. Further analysis is provided in a separate deliverable to accomp...
$3,950.00 -
05 May 2014 | Asia Pacific | Market Research
Russia Urinalysis Market Data
Increase in Test Volume Creates a Favorable Market for Reagents
This study provides market data for the Russian urinalysis market. Market segments include sediment, dipstick, and integrated systems. Sediment and dipstick segments are further segmented by instruments and reagents. Integrated systems is further segmented by instruments. In this deliverable, market revenues, installed base units, and market share ...
$3,950.00 -
05 May 2014 | Asia Pacific | Market Research
Russia Hemostasis Market Data
Russian Governments Intensive Support for Development of the In vitro Diagnostics Industry Propels Adoption of High-end Analyzers
This study provides market data for the Russian hemostasis diagnostics market. Market segments include instruments and reagents. The study also includes market revenues, installed base units, and market share for hemostasis diagnostics. Further analysis is provided in a separate deliverable to accompany this data. The timeframe for this study is 20...
$3,950.00 -
27 Mar 2014 | Asia Pacific | Market Research
2013 APAC Healthcare Outlook
Changing Dynamics to Disrupt and Transform Healthcare in Asia-Pacific by 2018
Healthcare expenditure in Asia-Pacific is expected to continue growing over the next 6 years, as rising demand for better healthcare for patients spurs reforms. This would also increase life expectancy, resulting in a large elderly population requiring long-term care. This study covers the hospital, life sciences, advanced medical technology, and c...
$2,450.00 -
21 Mar 2014 | Asia Pacific | Market Outlook
Asia-Pacific Healthcare Outlook - 2014
Changing Landscape Impacting Lives
The study presents an outlook of the healthcare market in the Asia-Pacific. Good healthcare service can impact social issues, economics, and even the politics of a country. Governments need to meet these expectations, but rising costs in population and demographic shifts are causing them to falter. Disparity in care levels is also a concern, especi...
$4,950.00 -
27 Feb 2014 | Asia Pacific | Market Research
Product and Pipeline Assessment of the Global Orphan Drugs Market
Attractive Market Lures Hundreds of Innovators, Large and Small
The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immuniza...
$3,950.00 -
12 Feb 2014 | Asia Pacific | Market Research
Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry
Vigilance and Equanimity are the Needs of the Hour
The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...
$4,950.00
